Clinical Trial Update: Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for aflibercept as maintenance therapy after induction with aflibercept plus XELOX for first-line metastatic colorectal cancer; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Zaltrap (aflibercept) (aflibercept)

Snippet

Sponsor: Sanofi | Conditions: Colorectal Cancer Metastatic | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-04-18